Last update 12 Dec 2024
BPI-1178
Last update 12 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms BP I1178, BP-I1178, BPI 1178 + [1] |
Target |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with BPI-1178An Open-label, Single-arm, Investigator-initiated Phase I Clinical Study Evaluating BPI-1178 Capsules in Combination With Osimertinib Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With EGFR Mutations
评估BPI-1178胶囊在晚期实体瘤患者（包括HR+/HER2-晚期乳腺癌）中的耐受性、安全性及药代动力学和初步疗效的I/IIa期临床研究
[Translation] A Phase I/IIa clinical study to evaluate the tolerability, safety, pharmacokinetics and preliminary efficacy of BPI-1178 capsules in patients with advanced solid tumors (including HR+/HER2- advanced breast cancer)
A Phase 1/2a Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Efficacy of BPI-1178 Alone in Advanced Solid Tumor and of BPI-1178 in Combination With Endocrine Therapy in Advanced HR+/HER2- Breast Cancer
100 Clinical Results associated with BPI-1178
Login to view more data
100 Translational Medicine associated with BPI-1178
Login to view more data
100 Patents (Medical) associated with BPI-1178
Login to view more data
100 Deals associated with BPI-1178
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced breast cancer | Phase 2 | CN | 15 Jun 2020 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | CN | 15 Jun 2020 | |
| Hormone receptor positive HER2 negative breast cancer | Phase 2 | CN | 15 Jun 2020 | |
| Advanced Lung Non-Small Cell Carcinoma | Phase 1 | CN | - | 22 May 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free